<VariationArchive RecordType="classified" VariationID="635148" VariationName="NM_203290.4(POLR1C):c.616del (p.Gln206fs)" VariationType="Deletion" Accession="VCV000635148" Version="4" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-07-29" DateCreated="2019-07-22" MostRecentSubmission="2019-09-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="622982" VariationID="635148">
      <GeneList>
        <Gene Symbol="POLR1C" FullName="RNA polymerase I and III subunit C" GeneID="9533" HGNC_ID="HGNC:20194" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="43517089" stop="44461400" display_start="43517089" display_stop="44461400" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="43484776" stop="43489250" display_start="43484776" display_stop="43489250" Strand="+" />
          </Location>
          <OMIM>610060</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_203290.4(POLR1C):c.616del (p.Gln206fs)</Name>
      <CanonicalSPDI>NC_000006.12:43520386:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="43520387" stop="43520387" display_start="43520387" display_stop="43520387" variantLength="1" positionVCF="43520386" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="43488125" stop="43488125" display_start="43488125" display_stop="43488125" variantLength="1" positionVCF="43488124" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>Q206fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.43488126del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.43488126del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.43520388del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.43520388del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_028283.3" sequenceAccession="NG_028283" sequenceVersion="3" change="g.15687del">
            <Expression>NG_028283.3:g.15687del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_051658.1" sequenceAccession="NG_051658" sequenceVersion="1" change="g.60689del">
            <Expression>NG_051658.1:g.60689del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318876.2" sequenceAccession="NM_001318876" sequenceVersion="2" change="c.616del">
            <Expression>NM_001318876.2:c.616del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305805.1" sequenceAccession="NP_001305805" sequenceVersion="1" change="p.Gln206fs">
            <Expression>NP_001305805.1:p.Gln206fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363658.2" sequenceAccession="NM_001363658" sequenceVersion="2" change="c.616del">
            <Expression>NM_001363658.2:c.616del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350587.1" sequenceAccession="NP_001350587" sequenceVersion="1" change="p.Gln206fs">
            <Expression>NP_001350587.1:p.Gln206fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_203290.4" sequenceAccession="NM_203290" sequenceVersion="4" change="c.616del" MANESelect="true">
            <Expression>NM_203290.4:c.616del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_976035.1" sequenceAccession="NP_976035" sequenceVersion="1" change="p.Gln206fs">
            <Expression>NP_976035.1:p.Gln206fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1156407486" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_203290.4(POLR1C):c.616del (p.Gln206fs) AND Hypomyelinating leukodystrophy 11" Accession="RCV000788029" Version="3">
        <ClassifiedConditionList TraitSetID="22159">
          <ClassifiedCondition DB="MedGen" ID="C4225305">Hypomyelinating leukodystrophy 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_203290.4(POLR1C):c.616del (p.Gln206fs) AND multiple conditions" Accession="RCV000850586" Version="1">
        <ClassifiedConditionList TraitSetID="47081">
          <ClassifiedCondition DB="MedGen" ID="C4225305">Hypomyelinating leukodystrophy 11</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1855433">Treacher Collins syndrome 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-12-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-12-31" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-07-22" MostRecentSubmission="2019-09-21">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">610060</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="22159" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33610" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypomyelinating leukodystrophy 11</ElementValue>
                <XRef ID="MONDO:0014666" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HLD11</ElementValue>
                <XRef Type="MIM" ID="616494" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings: Neurologic dysfunction, typically predominated by motor dysfunction (progressive cerebellar dysfunction, and to a lesser extent extrapyramidal [i.e., dystonia], pyramidal [i.e., spasticity] and cognitive dysfunctions). Abnormal dentition (delayed dentition, hypodontia, oligodontia, and abnormally placed or shaped teeth). Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty. Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe. POLR3-related leukodystrophy and 4H leukodystrophy are the two recognized terms for five previously described overlapping clinical phenotypes (initially described as distinct entities before their molecular basis was known). These include: Hypomyelination, hypodontia, hypogonadotropic hypogonadism (4H syndrome); Ataxia, delayed dentition, and hypomyelination (ADDH); Tremor-ataxia with central hypomyelination (TACH); Leukodystrophy with oligodontia (LO); Hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC). Age of onset is typically in early childhood but later-onset cases have also been reported. An infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have pathogenic variants in POLR3A on exome sequencing. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other individuals with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome.</Attribute>
                <XRef ID="NBK99167" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22855961</ID>
                <ID Source="BookShelf">NBK99167</ID>
              </Citation>
              <XRef ID="88637" DB="Orphanet" />
              <XRef ID="C4225305" DB="MedGen" />
              <XRef ID="MONDO:0014666" DB="MONDO" />
              <XRef Type="MIM" ID="616494" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="47081" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5450" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Treacher Collins syndrome 3</ElementValue>
                <XRef ID="MONDO:0009558" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mandibulofacial dysostosis, Treacher Collins type, autosomal recessive</ElementValue>
                <XRef ID="Mandibulofacial+dysostosis%2C+Treacher+Collins+type%2C+autosomal+recessive/4444" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TCS3</ElementValue>
                <XRef Type="MIM" ID="248390" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Treacher Collins syndrome (TCS) is characterized by bilateral and symmetric downslanting palpebral fissures, malar hypoplasia, micrognathia, and external ear abnormalities. Hypoplasia of the zygomatic bones and mandible can cause significant feeding and respiratory difficulties. About 40%-50% of individuals have conductive hearing loss attributed most commonly to malformation of the ossicles and hypoplasia of the middle ear cavities. Inner ear structures tend to be normal. Other, less common abnormalities include cleft palate and unilateral or bilateral choanal stenosis or atresia. Typically intellect is normal.</Attribute>
                <XRef ID="NBK1532" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9125" />
                <XRef ID="9125" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301704</ID>
                <ID Source="BookShelf">NBK1532</ID>
              </Citation>
              <XRef ID="861" DB="Orphanet" />
              <XRef ID="C1855433" DB="MedGen" />
              <XRef ID="MONDO:0009558" DB="MONDO" />
              <XRef Type="MIM" ID="248390" DB="OMIM" />
            </Trait>
            <Trait ID="33610" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypomyelinating leukodystrophy 11</ElementValue>
                <XRef ID="MONDO:0014666" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HLD11</ElementValue>
                <XRef Type="MIM" ID="616494" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings: Neurologic dysfunction, typically predominated by motor dysfunction (progressive cerebellar dysfunction, and to a lesser extent extrapyramidal [i.e., dystonia], pyramidal [i.e., spasticity] and cognitive dysfunctions). Abnormal dentition (delayed dentition, hypodontia, oligodontia, and abnormally placed or shaped teeth). Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty. Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe. POLR3-related leukodystrophy and 4H leukodystrophy are the two recognized terms for five previously described overlapping clinical phenotypes (initially described as distinct entities before their molecular basis was known). These include: Hypomyelination, hypodontia, hypogonadotropic hypogonadism (4H syndrome); Ataxia, delayed dentition, and hypomyelination (ADDH); Tremor-ataxia with central hypomyelination (TACH); Leukodystrophy with oligodontia (LO); Hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC). Age of onset is typically in early childhood but later-onset cases have also been reported. An infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have pathogenic variants in POLR3A on exome sequencing. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other individuals with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome.</Attribute>
                <XRef ID="NBK99167" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22855961</ID>
                <ID Source="BookShelf">NBK99167</ID>
              </Citation>
              <XRef ID="88637" DB="Orphanet" />
              <XRef ID="C4225305" DB="MedGen" />
              <XRef ID="MONDO:0014666" DB="MONDO" />
              <XRef Type="MIM" ID="616494" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1808251" SubmissionDate="2019-01-21" DateLastUpdated="2019-07-22" DateCreated="2019-07-22">
        <ClinVarSubmissionID localKey="NM_203290.3:c.615delC|Leukodystrophy, hypomyelinating, 11" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000924603" DateUpdated="2019-07-22" DateCreated="2019-07-22" Type="SCV" Version="1" SubmitterName="MyeliNeuroGene Lab, McGill University Health Center Research Institute" OrgID="320379" OrganizationCategory="laboratory" OrgAbbreviation="MNG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">610060</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLR1C" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_203290.3:c.615delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Leukodystrophy, hypomyelinating, 11</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5043960</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1946451" SubmissionDate="2019-03-14" DateLastUpdated="2019-09-21" DateCreated="2019-09-21">
        <ClinVarSubmissionID localKey="NC_000006.11:g.43488126delC|OMIM:616494;248390" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000992808" DateUpdated="2019-09-21" DateCreated="2019-09-21" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLR1C" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.43488126delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616494" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="248390" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5321481</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1946451" TraitType="Disease" MappingType="XRef" MappingValue="616494" MappingRef="OMIM">
        <MedGen CUI="C4225305" Name="Hypomyelinating leukodystrophy 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1808251" TraitType="Disease" MappingType="Name" MappingValue="Leukodystrophy, hypomyelinating, 11" MappingRef="Preferred">
        <MedGen CUI="C4225305" Name="Hypomyelinating leukodystrophy 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1946451" TraitType="Disease" MappingType="XRef" MappingValue="248390" MappingRef="OMIM">
        <MedGen CUI="C1855433" Name="Treacher Collins syndrome 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

